Form 8-K - Current report:
SEC Accession No. 0000950123-21-007391
Filing Date
2021-05-28
Accepted
2021-05-28 09:05:44
Documents
12
Period of Report
2021-05-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K eq-20210526.htm   iXBRL 8-K 56424
  Complete submission text file 0000950123-21-007391.txt   177515

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eq-20210526.xsd EX-101.SCH 2435
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eq-20210526_lab.xml EX-101.LAB 14046
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eq-20210526_pre.xml EX-101.PRE 10378
5 EXTRACTED XBRL INSTANCE DOCUMENT eq-20210526_htm.xml XML 4886
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 21976564
SIC: 2834 Pharmaceutical Preparations